[1] 王伽伯,张乐,郭玉明,等.中药药源性肝损伤因果关系的评价策略和方法[J]. 药学学报,2018,53(6):920-928.
[2] 罗琼,杨涛,刘成海.中草药药源性肝损伤的研究难点[J].中西医结合肝病杂志,2020,30(1):17-19.
[3] Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update[J]. Int J Mol Sci,2015,17(1):14-46.
[4] Devarbhavi H, Aithal G, Treeprasertsuk S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines[J]. Hepatol Int,2021,15(2):258-282.
[5] 中华中医药学会肝胆病分会,中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].中国中西医结合杂志,2016,36(6):645-653.
[6] Chen Y, Wang C, Yang H, et al. Epidemiology of drug-and herb-induced liver injury assessed for causality using the updated RUCAM in two hospitals from China[J]. Biomed Res Int,2021,2021:8894498.
[7] 仇丽霞,范作鹏,刘颖,等.一种改良诊断量表在急性药物性肝损伤诊断中的应用[J].临床肝胆病杂志,2017,33(7):1328-1331.
[8] 于乐成,刘鸿凌,赵新颜,等.2021版《ACG临床指南:特异质性药物性肝损伤的诊断和处理》精粹介绍及相关思考[J].肝脏,2021,26(5):465-476.
[9] 于乐成,陈成伟.新版RUCAM:药物和草药诱导性肝损伤的重要评估工具[J].肝脏,2016,21(6):493-500.
[10] 朱云,李永纲,王葽,等.595例中药导致肝损伤临床特征分析[J].中国中西医结合杂志,2016,36(1):43-47.
[11] Teschke R, Danan G. Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)[J]. Diagnostics (Basel),2021,11(3):458.
[12] 冉姗,方忠宏,黄海茵,等.中药药物性肝损伤报告中存在的问题及建议[J].中医杂志,2021,62(7):581-584.
[13] Zhu Y, Niu M, Chen J, et al. Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients[J]. J Gastroenterol Hepatol,2016,31(8):1476-1482.
[14] Hayashi PH, Lucena MI, Fontana RJ, et al. A revised electronic version of RUCAM for the diagnosis of DILI[J]. Hepatology,2022,76(1):18-31. |
